Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115613264 | 11561326 | 4 | F | 20150729 | 20160909 | 20150928 | 20160918 | EXP | PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-062668 | BRISTOL MYERS SQUIBB | 74.00 | YR | F | Y | 73.00000 | KG | 20160918 | OT | PL | PL |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115613264 | 11561326 | 1 | SS | CARBOPLATIN. | CARBOPLATIN | 1 | Intravenous (not otherwise specified) | 460 MG, Q3WK | 1380 | MG | Y | 0 | 460 | MG | Q3W | ||||
| 115613264 | 11561326 | 2 | PS | GLUCOPHAGE XR | METFORMIN HYDROCHLORIDE | 1 | Oral | 500 MG, QD | Y | 20357 | 500 | MG | QD | ||||||
| 115613264 | 11561326 | 3 | SS | EXTERNAL-DOCETAXEL | DOCETAXEL | 1 | Intravenous (not otherwise specified) | 106 MG, Q3WK | 318 | MG | Y | 0 | 106 | MG | Q3W | ||||
| 115613264 | 11561326 | 4 | SS | EXTERNAL-TRASTUZUMAB | TRASTUZUMAB | 1 | Intravenous (not otherwise specified) | 456 MG, Q3WK | 0 | 456 | MG | Q3W | |||||||
| 115613264 | 11561326 | 5 | C | EUTHYROX | LEVOTHYROXINE SODIUM | 1 | Unknown | UNK | D | 0 | |||||||||
| 115613264 | 11561326 | 6 | C | BIOSOTAL | 2 | Unknown | UNK | D | 0 | ||||||||||
| 115613264 | 11561326 | 7 | C | FLUANXOL /00109702/ | FLUPENTIXOL | 1 | Unknown | UNK | D | 0 | |||||||||
| 115613264 | 11561326 | 8 | C | ANAFRANIL | CLOMIPRAMINE HYDROCHLORIDE | 1 | Unknown | UNK | D | 0 | |||||||||
| 115613264 | 11561326 | 9 | C | SORTIS | ATORVASTATIN | 1 | Unknown | UNK | D | 0 | |||||||||
| 115613264 | 11561326 | 10 | C | KARBIS | CANDESARTAN CILEXETIL | 1 | Unknown | UNK | D | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 115613264 | 11561326 | 1 | Breast cancer |
| 115613264 | 11561326 | 2 | Diabetes mellitus |
| 115613264 | 11561326 | 3 | Breast cancer |
| 115613264 | 11561326 | 4 | Breast cancer |
| 115613264 | 11561326 | 5 | Hypothyroidism |
| 115613264 | 11561326 | 6 | Arrhythmia |
| 115613264 | 11561326 | 7 | Depression |
| 115613264 | 11561326 | 8 | Depression |
| 115613264 | 11561326 | 9 | Hypercholesterolaemia |
| 115613264 | 11561326 | 10 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 115613264 | 11561326 | OT |
| 115613264 | 11561326 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 115613264 | 11561326 | Asthenia | |
| 115613264 | 11561326 | Dehydration | |
| 115613264 | 11561326 | Diarrhoea | |
| 115613264 | 11561326 | Hypokalaemia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 115613264 | 11561326 | 1 | 20150518 | 20150720 | 0 | |
| 115613264 | 11561326 | 2 | 20110101 | 0 | ||
| 115613264 | 11561326 | 3 | 20150518 | 20150720 | 0 | |
| 115613264 | 11561326 | 4 | 20150518 | 0 | ||
| 115613264 | 11561326 | 5 | 20090101 | 0 | ||
| 115613264 | 11561326 | 6 | 20130101 | 0 | ||
| 115613264 | 11561326 | 7 | 20090101 | 0 | ||
| 115613264 | 11561326 | 8 | 19850101 | 0 | ||
| 115613264 | 11561326 | 9 | 20100101 | 0 | ||
| 115613264 | 11561326 | 10 | 20130101 | 0 |